参考文献/References:
[1].Xin T,Lv W,Liu D,et al. Opa1 reduces hypoxia-induced cardiomyocyte death by improving mitochondrial quality control[J]. Front Cell Dev Biol,2020,8:853.
[2].Wu L,Tan JL,Chen ZY,et al. Cardio-protection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening[J].. Basic Res Cardiol,2019,114(5):39.
[3].Xu T,Ding W,Ao X,et al. ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening[J]. Redox Biol,2019,20:414-426.
[4].Chen?W,Zhao?H,LiY. Mitochondrial dynamics in health and disease:mechanisms and potential targets[J]. Signal Transduct Target Ther, 2023,8(1):333.
[5].Ndrepepa G,Kastrati A. Coronary no-reflow after primary percutaneous coronary intervention—Current knowledge on pathophysiology,diagnosis,clinical impact and therapy[J]. Clin Med ,2023,12(17):5592.
[6].Heusch G,Andreadou I,Bell R,et al. Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardio-protection[J]. Redox Biol,2023,67:102894.
[7].Tokuyama T,Yanagi S. Role of mitochondrial dynamics in heart diseases[J]. Genes (Basel),2023,14(10):1876.
[8].Cao T, Fan S, Zheng D ,et al. Increased calpain-1 in mitochondria induces dilated heart failure in mice:Role of mitochondrial superoxide anion[J]. Basic Res Cardiol. 2019 ,114(3):17.
[9].Torrealba N,Aranguiz P,Alonso C,et al. Mitochondria in structural and functional cardiac remodeling[J]. Adv Exp Med Biol,2017,982:277-306.
[10].Eiringhaus J,Herting J,Schatter F,et al. Protein kinase/phosphatase balance mediates the effects of increased late sodium current on ventricular calcium cycling[J]. Basic Res Cardiol ,2019,114(2):13.
[11].Bussi C,Heunis T,Pellegrino E,et al.?Lysosomal damage drives mitochondrial proteome remodelling and reprograms macrophage immunometabolism[J].?Nat Commun,2022,13(1):7338.
[12].Boyman L,Greiser M,Lederer WJ. Calcium influx through the mitochondrial calcium uniporter holocomplex,MCUcx. J Mol Cell Cardiol,2021,151:145-154.
[13].Chen CL,Zhang L,Jin Z,et al. Mitochondrial redox regulation and myocardial ischemia-reperfusion injury[J]. Am J Physiol Cell Physiol,2022,322(1):C12-C23.
[14].Li Y,Hu H,Chu C,et al. Mitochondrial calcium uniporter complex:an emerging therapeutic target for cardiovascular diseases[J]. Int J Mol Med,2025,55(3):40.
[15].Fang Z,Zhao G,Zhao S,et al. GTF2H4 regulates partial EndMT via NF-κB activation through NCOA3 phosphorylation in ischemic diseases[J]. Innovation (Camb),2024,5(2):100565.
[16].李竹,王嫣,周雯静,等. 线粒体呼吸链酶复合物在心肌缺血再灌注损伤中的作用进展[J]. 实用医学杂志,2024,40(15):2172-2176.
[17].Hurst S,Gonnot F,Dia M,et al. Phosphorylation of cyclophilin D at serine 191 regulates mitochondrial permeability transition pore opening and cell death after ischemia-reperfusion[J]. Cell Death Dis,2020,11(8):661
[18].胡爽,温静,范晓迪,等.线粒体相关内质网膜及其在心肌缺血/再灌注损伤中作用的研究进展[J]. 中国药理学通报,2024,40(6):1001-1006.
[19].Xie Q,Wu H,Long H,et al. Secondary follicles enable efficient germline mt DNA base editing at hard-to-edit site[J]. Mol Ther Nucleic Acids,2024,35(2):102170.
[20].Niu X,Zhang J,Hu S.et al. lncRNA Oip5-as1 inhibits excessive mitochondrial fission in myocardial ischemia/reperfusion injury by modulating DRP1 phosphorylation[J]. Cell Mol Biol Lett,2024,29(1):72.
[21].Liu N,Kataoka M,Wang Y,et al. LncRNA LncHrt preserves cardiac metabolic homeostasis and heart function by modulating the LKB1-AMPK signaling pathway [J]. Basic ResCardiol.2021,116(1):48.
[22].Matsuda N,Sato S,Shiba K,et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy[J]. Cell Biol ,2010,189:211-221.
[23].Titus AS,Sung EA,Zablocki D,et al. Mitophagy for cardio-protection[J]. Basic Res Cardiol,2023,118(1):42.
[24].胡永洪,王嫣,王海英.?线粒体动力学相关蛋白在心肌缺血再灌注损伤中的作用研究进展[J]. 国际麻醉学与复苏杂志,2025,46(2):203-208.
[25].Hoshino A,Wang WJ,Wada S,et al. The ADP/ATP translocase drives mitophagy independent of nucleotide exchange[J]. Nature,2019,575(7782):375-379.
[26].Dubois Deruy E,Peugnet V,Turkieh A,et al. Oxidative stress in cardiovascular diseases[J]. Antioxidants (Basel),2020,9(9):864.
[27].Zhou T,Pan J,Xu K,et al. Single-cell transcriptomics in MI identify Slc25a4 as a new modulator of mitochondrial malfunction and apoptosis-associated cardiomyocyte subcluster[J]. Sci Rep,2024,14(1):9274.
[28].Jin J,Wei X,Zhi X,et al. Drp1-dependent mitochondrial fission in cardiovascular disease[J]. Acta Pharmacol Sin,2021,42(5):655-664.
[29].Li A,Zhang T,Huang T,et al. Iron oxide nanoparticles promote Cx43-overexpression of mesenchymal stem cells for efficient suicide gene therapy during glioma treatment[J]. Theranostics,2021,11(17):8254-8269.
[30].Zhang N,Fan M,Zhao Y,et al. Biomimetic and NOS-responsive nanomotor deeply delivery a combination of MSC-EV and mitochondrial ROS scavenger and promote heart repair and regeneration[J]. Adv Sci (Weinh),2023,10(21):e2301440.
[31].Yan R,Sun Y,Yang Y,et al. Mitochondria and NLRP3 inflammasome in cardiac hypertrophy[J]. Mol Cell Biochem,2024,479(7):1571-1582.
[32].Meng W,Zhu J,Wang Y,et al. Targeting delivery of miR-146a via IMTP modified milk exosomes exerted cardioprotective effects by inhibiting NF-κB signaling pathway after myocardial ischemia-reperfusion injury[J]. Nanobiotechnology,2024,22(1):382.
[33].Ai L,Freitas GJ,Huang C,et al. Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction:role of PR-364[J]. Eur Heart J,2025,46(4):380-393.
[34].Tan J,Min J,Jiang Y,et al. CircCHSY1 protects hearts against ischaemia/reperfusion injury by enhancing heme oxygenase 1 expression via miR-24-3p[J]. Cardiovasc Res ,2024,120(15):1924-1938.
[35].Chaudhari SN,Kipreos ET. Increased mitochondrial fusion allows the survival of older animals in diverse C. elegans longevity pathways[J]. Nat Commun,2017,8(1):182.
[36].Parvez S,Kaushik M,Ali M,et al. Dodging blood brain barrier with "nano" warriors:Novel strategy against ischemic stroke[J]. Theranostics,2022,12(2):689-719.
[37].Su X,Zhou M,Li Y,et al. Protective effects of natural products against myocardial ischemia/reperfusion:Mitochondria-targeted therapeutics[J]. Biomed Pharmacother,2022,149:112893.
[38].Eugenin E,Camporesi E,Peracchia C. Direct cell-cell communication via membrane pores,gap junction channels,and tunneling nanotubes:medical relevance of mitochondrial exchange[J]. Int J Mol Sci,2022,23(11):6133.
[39].[39] Driscoll J,Gondaliya P,Patel T. Tunneling nanotube-mediated communication:a mechanism of intercellular nucleic acid transfer[J]. Int J Mol Sci,2022,23(10):5487.
相似文献/References:
[1]田丁,张俊峰.心肌缺血早期诊断的无创检查方法进展[J].心血管病学进展,2016,(1):19.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.006]
TIAN Ding,ZHANG Junfeng.Review of Noninvasive Screening Methods Development in Early Diagnosis of
Myocardial Ischemia[J].Advances in Cardiovascular Diseases,2016,(9):19.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.006]
[2]谢乃容 赵薇 秦明照.缺血伴非阻塞性冠状动脉疾病研究进展[J].心血管病学进展,2019,(8):1134.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]
XIE NairongZHAO WeiQIN Mingzhao.Ischemia with No Obstructive Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2019,(9):1134.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]
[3]季春影 张瑞英.心力衰竭与心肌线粒体代谢[J].心血管病学进展,2020,(1):63.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.017]
JI ChunyingZHANG Ruiying.Heart Failure and Myocardial Mitochondrial Metabolism[J].Advances in Cardiovascular Diseases,2020,(9):63.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.017]
[4]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(9):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[5]严宁,杨春霞,马娟,等.β-谷甾醇对大鼠心肌缺血再灌注损伤和ERK1/2信号通路的影响[J].心血管病学进展,2020,(3):321.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.026]
YAN Ning,YANG Chunxia,MA Juan,et al.Effects of -sitosterolon Myocardial Ischemia-reperfusion Injury and ERK1/2 Signaling Pathway in Rats[J].Advances in Cardiovascular Diseases,2020,(9):321.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.026]
[6]麦兆康 周滔.冠状动脉内心电图的临床应用研究进展[J].心血管病学进展,2020,(8):817.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.009]
MAI ZhaokangZHOU Tao.Clinical Application of Intracoronary Electrocardiogram[J].Advances in Cardiovascular Diseases,2020,(9):817.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.009]
[7]刘家汝 关秀茹.Nrf2/ARE信号通路在动脉粥样硬化中的研究新进展[J].心血管病学进展,2020,(8):859.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.019]
LIU Jiaru,GUAN Xiuru.Nrf2/ARE Signaling Pathway in Atherosclerosis[J].Advances in Cardiovascular Diseases,2020,(9):859.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.019]
[8]王瑞钰,彭琳茜,李灵姣,等.硫氧还蛋白系统与高血压的研究进展[J].心血管病学进展,2020,(10):1036.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.009]
WANG RuiyuPENG LinqianLI LingjiaoXUE QianWANG LiangDU WeiHUANG Jing.Thioredoxin System in Hypertension[J].Advances in Cardiovascular Diseases,2020,(9):1036.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.009]
[9]李丹 徐蔓 唐其柱.Nox5在心血管疾病中的作用[J].心血管病学进展,2020,(12):1302.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.019]
Li Dan,Xu Man,Tang Qizhu.The Role of Nox5 in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(9):1302.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.019]
[10]李海通 闫莉.甲状腺疾病相关肺动脉高压发病机制研究进展[J].心血管病学进展,2021,(3):232.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.010]
LI Haitong,YAN Li.Pathogenesis of Thyroid Disease-related Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2021,(9):232.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.010]